Prof. Carlo Gabriele Tocchetti is Director of Cardio-Pulmonary Onco-Immunology at Federico II University Hospital, Naples, Italy where he has established himself as a HF basic and clinical investigator. Prof Tocchetti is Fellow of the HFA, Chair of the Study Group in Immunotherapy, ESC Council on Cardio-Oncology (CCO); Chair of the Committee on Cardio-Oncology, Heart Failure Association of the ESC; President, International Cardio-Oncology Society (ICOS) Italy Chapter and ICOS Executive Board Member.
The main goal of his group is to explore pathophysiologic mechanisms and therapeutic targets in cardiac dysfunction, with a particular interest on post-ischemic HF, genetic and inflammatory cardiomyopathies, Pulmonary Hypertension and RV dysfunction, and HF due to antineoplastic therapies, including novel anticancer immunotherapies and biologic drugs employed in inflammatory diseases.
